A charitable bequest is a gift to a person or an organization under a will or trust.With a will, a person is able to direct the distribution of his/her assets to those family members, individuals, and institutions that he/she cares about most and offers the following benefits.
- Flexibility. Because you are not actually making a gift until after your lifetime, you can change your mind at any time.
- Versatility. You can structure the bequest to leave a specific item or amount of money, make the gift contingent on certain events, or leave a percentage of your estate to us.
- Tax Relief. If your estate is subject to estate tax, your gift is entitled to an estate tax charitable deduction for the gift's full value. You may also be able to save on capital gains taxes if the property you leave has appreciated in value.
Donors may name the American Parkinson Disease Association (APDA) in a will or trust by simply including APDA's full legal name along with the tax ID number and mailing address as follows:
American Parkinson Disease Association
135 Parkinson Avenue
Staten Island, NY 10305
Tax ID – 13-1962771
There are several types of bequests that donors may choose from which are listed below along with some suggested language that may help. APDA suggests donors work with a financial advisor and/or lawyer to determine which options are best suited to the donor.
- A general bequest designates a specific dollar amount of cash. Example: "I give to the American Parkinson Disease Association, the sum of XXXXX dollars ($XXXX) to be used for its tax-exempt purpose(s)."
- A specific bequest identifies a specific item of property. Example: "I give to the American Parkinson Disease Association, all my shares of stock (in name of company), to be used for its tax-exempt purpose(s)."
- A residual bequest gives all or a portion of what remains in an estate after all debts, taxes, expenses, and all other bequests have been paid. Example: "I give to the American Parkinson Disease Association, XX% of the rest, residue, and remainder of my estate, to be used for its tax-exempt purpose(s)."
- A contingent bequest only takes effect under certain conditions such as the prior death of other beneficiaries; or, if a living beneficiary disclaims a bequest made to that beneficiary. To provide for this possibility, you may name an individual or a charitable organization as an alternate or contingent beneficiary. Example: "In the event that (beneficiary) predeceases me, I give to the American Parkinson Disease Association, (describe the asset), to be used for its tax-exempt purpose(s)."
- A restricted bequest: You may choose to restrict your bequest to a specific purpose. Example: "I give XXXXXXX ($XXXX) to the American Parkinson Disease Association, to establish a permanent endowment to be known as the (insert name) Fund. The income from this endowment shall be used to support (insert area of support)."
It is entirely up to the donor how funds are to be designated. Unrestricted funds allow APDA the flexibility to support the most pressing needs at the time of the distribution. However, donors are free to restrict support to focus either on 1) programs and services to help Ease the Burden, or 2) research to Find the Cure.
Below are the mission areas you may restrict funding to. In addition, APDA is happy to work with donors to discuss these options.
- Programs and Services – APDA has a vast network of community-based services throughout the country delivered by chapters and Information & Referral (I&R) Centers that provide programs, services, and resources to facilitate a better quality of life for the Parkinson's community. Funds designated to Programs and Services might fully support an APDA I&R Center, or help create signature health and wellness programs and services delivered throughout network such as Tai Chi, Yoga or dance.
- Research Grant Program – APDA prides itself in its ability attract young scientists who are new to the PD field, fund promising research that provides a pipeline to the future and fund pilot demonstration projects that are routinely leveraged for further funding. Our goal is to expedite the pace of research funding to support new clinical approaches to the search for a cure, while continuing to play a leading role in developing the clinical careers of young physicians and scientists dedicated to working on Parkinson's disease.